Friends and family top health influencers, says survey

Share this article:
Underscoring the importance of social media in public health, patients say friends and family are as responsible for their health as are medical professionals, according to Edelman's 2011 Health Barometer study.

Nearly half of respondents (43%) to the global survey said that their friends and family have the biggest impact on their lifestyle with regards to health after themselves, and more than a third (36%) cited friends and family as top influencers when it comes to nutrition.

Edelman surveyed 15,000 people in 12 countries and found that friends and family uniformly rank high among influencers on a range of health-related topics.

Respondents rated doctors the most credible sources of health info (88%), followed by pharmacists (81%), nurses (77%) and nutritionists (75%). Company experts placed in the middle of the pack, with 62% calling them credible – a little less than “Someone living with a disease/condition (65%)” but better than friends and family (55%). Celebs placed dead last (17%), followed by CEOs (22%), and reporters weren't far ahead (29%).

The PR giant identified an “action gap” in the survey data between desire to be healthier and the ability to change. More than half of respondents said they engage in at least one unhealthy behavior, and while 62% said they'd tried to change, half of those patients failed, mainly due to addiction/dependency and lack of enjoyment or immediate reward, along with a lack of support.

“Individuals have a powerful influence not just over their own health but also those around them,” said Edelman's Nick Fahy, a former European Commission health official. “We must be aware fo the impact that we can have. Just as poor health choices can be spread through social networks, so can good ones.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...